Cargando…
Serological Responses and Predictive Factors of Booster COVID-19 Vaccines in Patients with Hematologic Malignancies
Patients with hematologic malignancies are reported to have a more severe course of coronavirus disease 2019 (COVID-19) and be less responsive to vaccination. In this prospective study, we aimed to evaluate the serological responses to booster COVID-19 vaccines of Taiwanese patients with hematologic...
Autores principales: | Huang, Chien-Tzu, Lee, Ching-Ping, Chen, Tzu-Yin, Liu, Yi-Chang, Cho, Shih-Feng, Du, Jeng-Shiun, Yu, Ming-Lung, Huang, Chung-Feng, Wang, Sheng-Fan, Hsiao, Hui-Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10488979/ https://www.ncbi.nlm.nih.gov/pubmed/37685720 http://dx.doi.org/10.3390/jcm12175647 |
Ejemplares similares
-
Revisit of the Association between Cytomegalovirus Infection and Invasive Fungal Infection after Allogeneic Hematopoietic Stem Cell Transplantation: A Real-World Analysis from a High CMV Seroprevalence Area
por: Yeh, Tsung-Jang, et al.
Publicado: (2022) -
Deciphering the Functions of Telomerase Reverse Transcriptase in Head and Neck Cancer
por: Yeh, Tsung-Jang, et al.
Publicado: (2023) -
Effect of Tumor Microenvironment and Angiogenesis on Clinical Outcomes of Primary Central Nervous System Lymphoma
por: Wang, Hui-Ching, et al.
Publicado: (2021) -
Emodin Ameliorates the Efficacy of Carfilzomib in Multiple Myeloma Cells via Apoptosis and Autophagy
por: Hsu, Chin-Mu, et al.
Publicado: (2022) -
2334. The effectiveness of bivalent COVID-19 booster among patients with hematologic malignancies
por: Aleissa, Muneerah M, et al.
Publicado: (2023)